RBC Europe’s Gossamer Bio GOSS Stock Holding History

RBC Europe’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-169	Closed	-$2.12K	–	832
2021 Q3	$2.12K	Hold	169	–	–	﹤0.01%	1119
2021 Q2	$1.37K	Hold	169	–	–	﹤0.01%	1161
2021 Q1	$1.56K	Hold	169	–	–	﹤0.01%	1098
2020 Q4	$1.63K	Hold	169	–	–	﹤0.01%	1057
2020 Q3	$2.1K	Hold	169	–	–	﹤0.01%	981
2020 Q2	$2.2K	Hold	169	–	–	﹤0.01%	952
2020 Q1	$1.72K	Buy	+169	New	+$2.21K	﹤0.01%	928

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

RBC Europe's GOSS Position: Q4 2021 in Review

RBC Europe sold out of Gossamer Bio (GOSS) in Q4 2021, closing a stake of 169 shares — an estimated $2.12K sold.

RBC Europe first reported a position in GOSS in Q1 2020 and held it in 7 quarters. The position peaked at $2.2K in Q2 2020. 133 funds tracked by Wall St. Rank hold GOSS as of Q4 2021.

RBC Europe reported no remaining Gossamer Bio position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 169 Gossamer Bio shares in Q4 2021, an estimated $2.12K.
RBC Europe first reported a position in Gossamer Bio in Q1 2020 and held it in 7 quarters.
RBC Europe's Gossamer Bio position peaked at $2.2K in Q2 2020.
133 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.